Last reviewed · How we verify
Stools
At a glance
| Generic name | Stools |
|---|---|
| Sponsor | Versailles Hospital |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions (Phase 4)
- Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics (N/A)
- Digestion and Transit of Food DNA Through the Human Gut (NA)
- Study of Factors Influencing the Dynamicsof Colonisation and Decolonisation of the Digestive Tract by Clostridioides Difficile in Infants (NA)
- Comparison of the Gut Microbiota Composition in Caucasian Hispanic and Caucasian Non-Hispanic Children With and Without Obesity (N/A)
- Vancomycin and Fecal Microbiota Transplant in a Single Patient for the Treatment of Autism Spectrum Disorder (N/A)
- Randomized Controlled Pilot Clinical Study Including Kombucha in the Diet of Individuals with Overweight and Class 1 Obesity: Comparative Assessment Between Live and Pasteurized Kombucha and Its Effec (NA)
- Oral Aromatase Inhibitors Modify the Gut Microbiome Effecting Estrogen Bioavailability (N/A)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Stools CI brief — competitive landscape report
- Stools updates RSS · CI watch RSS
- Versailles Hospital portfolio CI